Phase II trial of CH5424802 (alectinib hydrochloride) for recurrent or refractory ALK-positive anaplastic large cell lymphoma: study protocol for a non-randomized non-controlled tr...

por Nagai, Hirokazu, Fukano, Reiji, Sekimizu, Masahiro, Kada, Akiko, M. Saito, Akiko, Asada, Ryuta, Mori, Tetsuya
Publicado 2017